datetime,headline,summary,related,lang,source
2020-11-03 10:45:00-05:00,"Global Orthopedic Prosthetics Market- Featuring Blatchford Ltd., Fillauer LLC, Globus Medical Inc., Among Others | Technavio",LONDON--(BUSINESS WIRE)-- #GlobalOrthopedicProstheticsMarket--The Global Orthopedic Prosthetics Market will grow by USD 468.88 mn during 2020-2024,GMED,en,Business Wire
2020-10-27 06:30:36-05:00,"Orthopedic Devices Market Top Key Players- Globus Medical Inc., B. Braun Melsungen AG, Medtronic Plc., Smith & Nephew Plc., Stryker Corporatio Growth Trends, quantitative analysis Industry Analysis and Market Dynamics of the Global Market, 2020 to 2027","Summary of the Orthopedic Devices Market Report Due to the various economic, technological, research & development and geographical aspects, the Orthopedic Devices Market would gain a healthy CAGR and market size from 2020 to 2027. The growth trend would",GMED,en,OpenPR
2020-10-26 09:06:54-05:00,"Lumbar Disc Herniation Treatment Market Is Projected To Gain Significant Value By 2020 - 2027 | Stryker Corporation, Medtronic, Zimmer Biomet Holdings, Globus Medical",Lumbar disc herniation treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence,GMED,en,OpenPR
2020-10-22 20:44:46-05:00,"Brokerages Anticipate Globus Medical, Inc. (NYSE:GMED) Will Announce Quarterly Sales of $197.71 Million","Brokerages predict that Globus Medical, Inc. (NYSE:GMED) will report sales of $197.71 million for the current quarter, Zacks reports. Six analysts have made estimates for Globus Medical’s earnings. The highest sales estimate is $201.31 million and the lowest is $194.30 million. Globus Medical reported sales of $196.22 million during the same quarter last year, which […]",GMED,en,US Banking News
2020-10-21 10:57:10-05:00,MORGAN STANLEY: Buy these 61 stocks that will offer major earnings-driven upside following an imminent 10% market sell-off,"Summary List Placement When it comes to his outlook on the market for the next few months, Morgan Stanley's Mike Wilson is pessimistic. The bank's chief US equity strategist and chief investment officer said in a Monday note that he expects the market to drop another 10% in the near term as investors face uncertainty around the election outcome, more fiscal stimulus, and another wave of COVID-19. But once the dust settles, Wilson said he expects the bull market to ensue — one which will be led by cyclical and smaller-cap stocks as earnings get a boost from the economic recovery. As such, Wilson recommended using a near term sell-off as a buying opportunity. ""We think the best opportunities lie in stocks where earnings are growing with the cyclical rebound and growing by enough to offset any valuation headwinds,"" Wilson said. He continued: ""On any pullbacks, we would look to our earnings upside screen from September — 66% of stocks have outperformed the market with median outperformance of 2.",GMED,en,Business Insider
2020-10-20 23:14:45-05:00,Globus Medical (GMED) Set to Announce Quarterly Earnings on Wednesday,"Globus Medical (NYSE:GMED) will post its quarterly earnings results after the market closes on Wednesday, October 28th. Analysts expect Globus Medical to post earnings of $0.30 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link. Globus Medical (NYSE:GMED) last posted its quarterly […]",GMED,en,US Banking News
2020-10-16 15:30:00-05:00,Globus Medical Schedules Third Quarter 2020 Earnings Release and Conference Call,"AUDUBON, Pa., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its…",GMED,en,GlobeNewswire
2020-10-09 08:32:44-05:00,"Cervical Total Disc Replacement Device Market Is Projected To Attain Substantial Absolute $ Opportunity In Terms Of Value Through 2026 | Stryker Corporation, Medtronic Plc, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., FH Orthopedics, Orthofix Medic","""Cervical Total Disc Replacement Device Market″ Report evaluated the historical and current performance of the market, especially highlighting the key trends and growth opportunities. Cervical Total Disc Replacement Device market report discussed this scenario of market size with reference to",GMED,en,OpenPR
2020-10-05 09:04:28-05:00,"Cervical Total Disc Replacement Device Market Expected To Boost The Global Industry Growth By 2026 | Stryker Corporation, Medtronic Plc, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., FH Orthopedics","""Cervical Total Disc Replacement Device Market″ Report evaluated the historical and current performance of the market, especially highlighting the key trends and growth opportunities. Cervical Total Disc Replacement Device market report discussed this scenario of market size with reference to",GMED,en,OpenPR
2020-10-01 02:11:08-05:00,"Global Vertebroplasty and Kyphoplasty Market 2027 In-Depth Analysis Globally by Top Key Players Globus Medical, IZI Medical Products, ZAVATION, RONTIS, G21 S.r.l., SOMATEX Medical Technologies","A new research study from “Data Bridge Market Research” with title Vertebroplasty and Kyphoplasty Insights 2020, Global Analysis and Forecast to 2027 provides an in-depth assessment of the Vertebroplasty and Kyphoplasty including key market trends, upcoming technologies, industry",GMED,en,OpenPR
2020-09-30 03:56:09-05:00,"Orthopedic Biomaterials Market to Reach USD 26.28 Billion By 2027 | Evonik Industries AG, Zimmer Biomet, Globus Medical, etc.",The current report on the Orthopedic Biomaterials Market provides a comprehensive assessment of the business vertical and offers a comprehensive overview of the industry along with its key segments. The study includes an accurate estimate of the current industry scenario,GMED,en,OpenPR
2020-08-12 11:30:00-05:00,"Global Spinal Fusion Market 2015-2030: Key Trends, Regional & Competitive Insights, COVID-19 Impact - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Spinal Fusion (Orthopedic Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)"" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Spinal Fusion market for the year 2020 and beyond. Companies Mentioned Medtronic plc NuVasive Inc. DePuy Synthes Inc. Globus Medical Inc. Stryker Corp. Zimmer Biomet Holdings Inc. Lumbar fusions are the most common spinal fusion procedures",GMED,en,Business Wire
2020-08-05 10:52:00-05:00,"Worldwide Interventional Spine Devices Market (2020 to 2024) - Featuring Alphatec Holdings, Globus Medical & Integra LifeSciences Among Others - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Global Interventional Spine Devices Market 2020-2024"" report has been added to ResearchAndMarkets.com's offering. The interventional spine devices market is poised to grow by $ 2.31 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. The report on the interventional spine devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The r",GMED,en,Business Wire
2020-07-21 15:15:00-05:00,Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call,"AUDUBON, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its…",GMED,en,GlobeNewswire
2020-06-26 09:12:51-05:00,Globus Medical Inc (NYSE: GMED) Q1 2020 Earnings Call Transcript | AlphaStreet,Globus Medical Inc (NYSE: GMED) Q1 2020 Earnings Conference Call Final Transcript,GMED,en,News Alphastreet
2020-06-25 18:50:00-05:00,COVID-19: Significant Shift in Strategy of Orthopedic Implants Market 2020-2024 | Rising Prevalence of Orthopedic Conditions to Augment Growth | Technavio,"Technavio has been monitoring the orthopedic implants market and it is poised to grow by USD 10.09 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200625005787/en/ Technavio has announced its latest market research report titled Global Orthopedic Implants Market 2020-2024 (Graphic: Business Wire). Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.",GMED,en,Benzinga Feeds
2020-06-09 04:05:00-05:00,Globus Medical Faces Business Loss Amid Coronavirus Crisis,"Globus Medical (GMED) notes that the U.S. spine business bottomed in the first full week of April, witnessing a decline of about 70% from its pre-COVID 19 pace.",GMED,en,Zacks Investment Research
2020-05-08 04:23:00-05:00,Globus Medical (GMED) Misses on Q1 Earnings and Revenues,Globus Medical (GMED) witnesses around $20 million of COVID-19 related adverse impact on its Q1 sales.,GMED,en,Zacks Investment Research
2020-05-07 19:50:06-05:00,Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates,"Globus Medical (GMED) delivered earnings and revenue surprises of -27.50% and -4.65%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",GMED,en,Zacks Investment Research
2020-03-21 10:30:55-05:00,Why Is Globus Medical (GMED) Down 28.9% Since Last Earnings Report?,Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,GMED,en,Zacks Investment Research
2020-03-18 14:28:09-05:00,BTIG Buys Into Globus Medical's Longer-Term Vision,"Globus Medical Inc’s (NYSE: GMED ) shares have declined around 33% from their year-end 2019 high, and the company has a strong balance sheet that can be used to acquire assets at depressed values, according to BTIG. The Globus Medical Analyst BTIG’s Ryan Zimmerman upgraded Globus Medical from Neutral to Buy and set a $46 price target. The Globus Medical Thesis Globus Medical’s installed base is approaching 100 units, a scale at which “implant pull-through will support sizable hardware growth,” Zimmerman said in the Wednesday upgrade note. (See his track record here .) Coronavirus-induced uncertainties could prevent a near-term rebound in shares, and there may be low demand for … Full story available on Benzinga.com",GMED,en,Benzinga
2020-02-25 02:30:00-05:00,Global Spinal Implants Market 2020-2024 | Evolving Opportunities with B. Braun Melsungen AG and Globus Medical Inc. | Technavio,LONDON--(BUSINESS WIRE)-- #GlobalSpinalImplantsMarket--The global spinal implants market is poised to grow by USD 2.75 billion during 2020-2024,GMED,en,Business Wire
2020-02-12 19:42:00-05:00,Stock Alert: Globus Medical (GMED),"Globus Medical Inc. (GMED) is all set to announce its financial results for the fourth quarter and full-year ended December 31, 2019, after the market close on February 20, 2020.",GMED,en,RTT News
2020-01-16 03:43:00-05:00,"Globus Medical Gains From International Spine Arm, Innovation",Globus Medical (GMED) delivers solid spine sales globally. Enabling Technologies too rides high on the rising uptake of ExcelsiusGPS platform.,GMED,en,Zacks Investment Research
2019-12-20 08:12:05-05:00,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering","The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 19.) Acceleron Pharma Inc (NASDAQ: XLRN ) Ardelyx Inc (NASDAQ: ARDX ) AstraZeneca plc (NYSE: AZN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (priced its 2-million-share common stock offering at $87 per share) Clearside Biomedical Inc (NASDAQ: CLSD ) Cortexyme Inc (NASDAQ: CRTX ) Cue Biopharma Inc (NASDAQ: CUE ) Exagen Inc (NASDAQ: XGN ) Globus Medical Inc (NYSE: GMED ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) (The acquisition vehicle announced merger with Immuvant, a clinical-stage biopharma company focusing on autoimmune disorders) IVERIC bio Inc (NASDAQ: ISEE ) Johnson & Johnson (NYSE: JNJ ) (Barclays upgraded shares to Overweight) The Medicines Company (NASDAQ: MDCO ) Merck & Co., Inc. (NYSE: MRK ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Monopar Therapeutics Inc. (NASDAQ: MNPR ) (Went public Thursday) Myokardia Inc (NASDAQ: MYOK ) NeoGenomics, Inc. (NASDAQ: NEO ) Novan Inc (NASDAQ: NOVN ) Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP ) Principia Biopharma Inc (NASDAQ: PRNB ) Quest Diagnostics Inc (NYSE: DGX ) Recro Pharma Inc (NASDAQ: REPH ) Sanofi SA (NASDAQ: SNY ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Down In The Dumps (Biotech stocks that hit 52-week lows Dec. 19.) Aethlon Medical, Inc. (NASDAQ: AEMD ) Anixa Biosciences Inc (NASDAQ: ANIX ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Correvio Pharma Corp (NASDAQ: …",GMED,en,Benzinga
2019-12-19 03:19:00-05:00,Here's Why You Should Hold on to Globus Medical Stock for Now,Investors continue to be optimistic about Globus Medical (GMED) on its stellar segmental performance.,GMED,en,Zacks Investment Research
2019-12-18 07:23:31-05:00,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17) Acceleron Pharma Inc (NASDAQ: XLRN ) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) Aptose Biosciences Inc (NASDAQ: APTO ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Globus Medical Inc (NYSE: GMED ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Iovance Biotherapeutics Inc (NASDAQ: IOVA ) Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) Medtronic PLC (NYSE: MDT )(announced acquisition of Klue, a software company focused on behavior tracking) Mirati Therapeutics Inc (NASDAQ: MRTX ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Nantkwest Inc (NASDAQ: NK ) Novo Nordisk A/S (NYSE: NVO ) Neoleukin Therapeutics Inc (NASDAQ: NLTX ) NuVasive, Inc. (NASDAQ: NUVA ) Ovid Therapeutics Inc (NASDAQ: OVID ) Prevail Therapeutics Inc (NASDAQ: PRVL )( announced Orphan Drug Designation for its dementia asset) Principia Biopharma Inc (NASDAQ: PRNB ) Repro-Med Systems, Inc. (NASDAQ: KRMD ) ResMed Inc. (NYSE: RMD ) Soligenix, Inc.",GMED,en,Benzinga
2019-12-13 08:10:02-05:00,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer","The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 12.) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) (received approval for its bone-building osteoporosis drug in the U.S.) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) Avenue Therapeutics Inc (NASDAQ: ATXI ) (submitted the NDA for intravenous tramadol for the management of moderate to moderately severe pain in adults in a medically supervised health care setting) Bausch Health Companies Inc (NYSE: BHC ) (reacted to upgrade to Overweight rating by JPMorgan) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Boston Scientific Corporation (NYSE: BSX ) Bristol-Myers Squibb Co (NYSE: BMY ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) Globus Medical Inc (NYSE: GMED ) (reacted to upgrade to Overweight by Wells Fargo Securities) Gossamer Bio Inc (NASDAQ: GOSS ) Hologic, Inc.",GMED,en,Benzinga Feeds
2019-12-10 07:56:02-05:00,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares","The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aptose Biosciences Inc (NASDAQ: APTO ) (moved on ASH presentation) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ), which agreed to be bought by Merck & Co., Inc. (NYSE: MRK ) Arvinas Inc (NASDAQ: ARVN ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) BridgeBio Pharma Inc (NASDAQ: BBIO ) (appointed oncology scientist Eli Wallace as chief scientific officer for its oncology programs) Bristol-Myers Squibb Co (NYSE: BMY ) (reacted to ASH presentation) Constellation Pharmaceuticals Inc (NASDAQ: CNST ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Epizyme Inc (NASDAQ: EPZM ) (reacted to ASH presentation) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) (reacted to ASH presentation) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Globus Medical Inc (NYSE: GMED ) Immunomedics, Inc.","GLPG,GMED",en,Benzinga
2019-12-06 11:31:11-05:00,Why Is Globus Medical (GMED) Up 3.9% Since Last Earnings Report?,Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,GMED,en,Zacks Investment Research
2019-11-27 07:26:05-05:00,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 26) Allakos Inc (NASDAQ: ALLK ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Ardelyx Inc (NASDAQ: ARDX ) ( announced a research collaboration with Japan's Kyowa Kirin and an investment in the company by the latter) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR )(reacted to its full-year results) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) ChemoCentryx Inc (NASDAQ: CCXI )( announced positive late-stage results for rare inflammation disease drug) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Global Blood Therapeutics Inc (NASDAQ: GBT )(announced FDA nod for sickle cell disease drug) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Globus Medical Inc (NYSE: GMED ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Merck & Co., Inc. (NYSE: MRK )(Keytruda was approved in China as a first-line treatment for lung cancer, in combination with chemotherapy) Molecular Templates Inc (NASDAQ: …",GMED,en,Benzinga
2019-11-26 08:06:41-05:00,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Arvinas Inc (NASDAQ: ARVN ) (Guggenheim initiated coverage of stock with Buy rating and $50 price target) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) (announced achievement of enrollment target in a Phase 3 trial of drug to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) BioNTech SE – ADR (NASDAQ: BNTX ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Epizyme Inc (NASDAQ: EPZM ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Globus Medical Inc (NYSE: GMED ) Halozyme Therapeutics, Inc.","GMED,GMAB",en,Benzinga
2019-11-20 07:25:05-05:00,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Allergan plc (NYSE: AGN )(announced publication of Phase 3 study results of migraine drug candidate) Agenus Inc (NASDAQ: AGEN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS )(announced a collaboration agreement with Idorsia Pharma for developing a drug-device combo for heart attack) Ardelyx Inc (NASDAQ: ARDX ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Arvinas Inc (NASDAQ: ARVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Cabaletta Bio Inc (NASDAQ: CABA ) CNS Pharmaceuticals Inc (NASDAQ: CNSP )(IPOed Nov. 8) Crispr Therapeutics AG (NASDAQ: CRSP )( announced positive Phase 1/2 results for gene-editing investigational therapy) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Edwards Lifesciences Corp (NYSE: EW ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Galera Therapeutics Inc (NASDAQ: GRTX )(IPOed Nov.",GMED,en,Benzinga
2019-11-12 03:41:00-05:00,"Globus Medical's U.S. Spine Arm Grows, Product Launches Aid",Globus Medical (GMED) is on course to commercially market ExcelsiusGPS platform and launch its spine deformity solution in early fourth quarter.,GMED,en,Zacks Investment Research
2019-11-12 00:30:53-05:00,Globus Medical (NYSE:GMED) Receives Hold Rating from BTIG Research,"BTIG Research restated their hold rating on shares of Globus Medical (NYSE:GMED) in a research note released on Thursday morning, AnalystRatings.com reports. A number of other research firms have also recently issued reports on GMED. Cantor Fitzgerald raised their target price on Globus Medical from $55.00 to $64.00 and gave the company an overweight rating […]",GMED,en,Modern Readers
2019-11-07 04:23:00-05:00,"Globus Medical (GMED) Q3 Earnings Meet Mark, Revenue View Up",Globus Medical (GMED) reports robust top-line numbers for the third quarter on segmental strength.,GMED,en,Zacks Investment Research
2019-10-30 09:34:02-05:00,Globus Medical (GMED) Earnings Expected to Grow: Should You Buy?,Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,GMED,en,Zacks Investment Research
2019-10-24 09:55:01-05:00,Did Hedge Funds Drop The Ball On Globus Medical Inc (GMED) ?,"Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons. Nevertheless, the data show elite investors' consensus picks have done well on average over the long-term. The top 20 stocks",GMED,en,ACI Information Group
2019-09-18 10:16:00-05:00,Here's Why You Should Retain Globus Medical (GMED) Stock Now,"Investor confidence continues to be high in Globus Medical (GMED), thanks to solid prospects.",GMED,en,Zacks Investment Research
2019-08-31 08:31:47-05:00,Globus Medical (GMED) Up 10.1% Since Last Earnings Report: Can It Continue?,Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,GMED,en,Zacks Investment Research
2019-08-02 10:38:00-05:00,"Globus Medical (GMED) Q2 Earnings In Line, Revenue View Up",Globus Medical's (GMED) spine business gains traction from solid worldwide growth in the second quarter.,GMED,en,Zacks Investment Research
2019-08-01 18:15:05-05:00,Globus Medical (GMED) Q2 Earnings Match Estimates,"Globus Medical (GMED) delivered earnings and revenue surprises of 0.00% and 5.77%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",GMED,en,Zacks Investment Research
2019-07-25 09:33:49-05:00,Earnings Preview: Globus Medical (GMED) Q2 Earnings Expected to Decline,Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,GMED,en,Zacks Investment Research
2019-05-24 02:23:00-05:00,Globus Medical Reveals Positive Study Results for ExcelsiusGPS,"Results of the study of ExcelsiusGPS reached a milestone for Globus Medical (GMED) in the field of robotics-assisted, minimally invasive pedicle screw placement procedure",GMED,en,Zacks Investment Research
2019-05-05 22:27:00-05:00,"Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised)","Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.",GMED,en,Zacks Investment Research
2019-05-03 00:37:00-05:00,"Globus Medical (GMED) Q1 Earnings Miss Mark, Margins Weak","Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.",GMED,en,Zacks Investment Research
2019-05-02 21:19:07-05:00,"Globus Medical, Inc. (GMED) CEO Dave Demski on Q1 2019 Results - Earnings Call Transcript","Globus Medical, Inc. (NYSE:GMED) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants Brian Kearns - Senior Vice President-Business Deve",GMED,en,Seeking Alpha
2019-05-02 19:58:25-05:00,Globus Medical Inc (GMED) Q1 2019 Earnings Call Transcript,"GMED earnings call for the period ending March 31, 2019.",GMED,en,The Motley Fool
2019-05-02 18:35:06-05:00,Globus Medical (GMED) Q1 Earnings and Revenues Miss Estimates,"Globus Medical (GMED) delivered earnings and revenue surprises of -12.20% and -1.90%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?",GMED,en,Zacks Investment Research
2019-05-02 15:21:38-05:00,"Globus Medical misses by $0.05, misses on revenue",No summary available.,GMED,en,Seeking Alpha
2019-04-25 09:34:30-05:00,Globus Medical (GMED) Reports Next Week: What Awaits?,Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,GMED,en,Zacks Investment Research
2019-04-01 04:27:00-05:00,"Globus Medical Global Base Solid, Pricing Scenario Bothers",Globus Medical (GMED) is upbeat about its growth prospects in the current and the emerging global markets through a continual expansion of direct and distributor sales forces.,GMED,en,Zacks Investment Research
2019-02-21 21:36:13-05:00,Globus Medical's (GMED) CEO Dave Demski on Q4 2018 Results - Earnings Call Transcript,"Globus Medical, Inc. (NYSE:GMED) Q4 2018 Earnings Conference Call February 21, 2019 4:30 PM ET Company Participants Brian Kearns – Vice President-Business Devel",GMED,en,Seeking Alpha
2019-02-21 16:23:01-05:00,"Globus Medical beats by $0.04, beats on revenue",No summary available.,GMED,en,Seeking Alpha
2019-02-20 17:35:07-05:00,Globus Medical Q4 Earnings Preview,No summary available.,GMED,en,Seeking Alpha
2019-02-12 11:22:08-05:00,"Medical devices maintain strength, IHI up 11% ytd",No summary available.,GMED,en,Seeking Alpha
2019-01-24 16:32:43-05:00,Anthem to cover Globus Med's Secure-C artificial disc,No summary available.,GMED,en,Seeking Alpha
